{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T12:12:30Z","timestamp":1768738350498,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,7,16]],"date-time":"2014-07-16T00:00:00Z","timestamp":1405468800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2261-14-86","type":"journal-article","created":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T23:01:20Z","timestamp":1405465280000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Myocardial fibrosis as the first sign of cardiac involvement in a male patient with Fabry disease: report of a clinical case and discussion on the utility of the magnetic resonance in Fabry pathology"],"prefix":"10.1186","volume":"14","author":[{"given":"Annalisa","family":"Sechi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Nucifora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Piccoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Dardis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Bembi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,7,16]]},"reference":[{"key":"735_CR1","first-page":"3733","volume-title":"The Metabolic and Molecular Bases of Inherited Disease","author":"R Desnick","year":"2001","unstructured":"Desnick R, Ioannou Y, Eng C: Alpha-Galactosidase A deficiency: Fabry disease. The Metabolic and Molecular Bases of Inherited Disease. Edited by: Scriver CR BA, Sly WS, Valle D. 2001, New York: McGraw-Hill, 3733-3774. 8","edition":"8"},{"key":"735_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/jmg.2005.036327","volume":"43","author":"PB Deegan","year":"2006","unstructured":"Deegan PB, Baehner AF, Barba Romero MA, Hughes DA, Kampmann C, Beck M, European FOS Investigators: Natural history of Fabry disease in females in the Fabry Outcome Survey. J Med Genet. 2006, 43: 347-352.","journal-title":"J Med Genet"},{"issue":"4 Suppl","key":"735_CR3","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/j.jpeds.2009.07.003","volume":"155","author":"AM Martins","year":"2009","unstructured":"Martins AM, D'Almeida V, Kyosen SO, Takata ET, Delgado AG, Gon\u00e7alves AM, Benetti Filho CC, Martini Filho D, Biagini G, Pimentel H, Abensur H, Guimar\u00e3es HC, Gomes JG, Sobral Neto J, D'Almeida LO, Carvalho LR, Harouche MB, Maldonado MC, Nascimento OJ, Montoril PS, Bastos RV: Guidelines to diagnosis and monitoring of Fabry disease and review of treatment experiences. J Pediatr. 2009, 155 (4 Suppl): S19-S31.","journal-title":"J Pediatr"},{"key":"735_CR4","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/sj.ki.5000208","volume":"69","author":"F Breunig","year":"2006","unstructured":"Breunig F, Weidemann F, Strotmann J, Knoll A, Wanner C: Clinical benefit of enzyme replacement therapy in Fabry disease. Kidney Int. 2006, 69: 1216-1221. 10.1038\/sj.ki.5000208.","journal-title":"Kidney Int"},{"key":"735_CR5","first-page":"2(6)","volume":"21","author":"MA Engelen","year":"2012","unstructured":"Engelen MA, Brand E, Baumeister TB, Marquardt T, Duning T, Osada N, Schaefer RM, Stypmann J: Effects of enzyme replacement therapy in adult patients with Fabry disease on cardiac structure and function: a retrospective cohort study of the Fabry Munster Study (FaMuS) data. BMJ Open. 2012, 21: 2(6)-","journal-title":"BMJ Open"},{"key":"735_CR6","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1136\/jmg.2008.065904","volume":"46","author":"A Mehta","year":"2009","unstructured":"Mehta A, Clarke JT, Giugliani R, Elliott P, Linhart A, Beck M, Sunder-Plassmann G, FOS Investigators: Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey. J Med Genet. 2009, 46: 548-552. 10.1136\/jmg.2008.065904.","journal-title":"J Med Genet"},{"key":"735_CR7","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1016\/j.ehj.2003.09.017","volume":"24","author":"JC Moon","year":"2003","unstructured":"Moon JC, Sachdev B, Elkington AG, McKenna WJ, Mehta A, Pennell DJ, Leed PJ, Elliott PM: Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J. 2003, 24: 2151-2155. 10.1016\/j.ehj.2003.09.017.","journal-title":"Eur Heart J"},{"key":"735_CR8","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1093\/eurheartj\/ehi143","volume":"26","author":"F Weidemann","year":"2005","unstructured":"Weidemann F, Breunig F, Beer M, Sandstede J, St\u00f6rk S, Voelker W, Ertl G, Knoll A, Wanner C, Strotmann JM: The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease. Eur Heart J. 2005, 26: 1221-1227. 10.1093\/eurheartj\/ehi143.","journal-title":"Eur Heart J"},{"key":"735_CR9","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.jcmg.2011.01.020","volume":"4","author":"M Niemann","year":"2011","unstructured":"Niemann M, Herrmann S, Hu K, Breunig F, Strotmann J, Beer M, Machann W, Voelker W, Ertl G, Wanner C, Weidemann F: Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment. JACC Cardiovasc Imaging. 2011, 4: 592-601. 10.1016\/j.jcmg.2011.01.020.","journal-title":"JACC Cardiovasc Imaging"},{"key":"735_CR10","doi-asserted-by":"publisher","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","volume":"138","author":"RJ Desnick","year":"2003","unstructured":"Desnick RJ, Brady R, Barranger J, Collins AJ, Germain DP, Goldman M, Grabowski G, Packman S, Wilcox WR: Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med. 2003, 138: 338-346. 10.7326\/0003-4819-138-4-200302180-00014.","journal-title":"Ann Intern Med"},{"key":"735_CR11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/01.gim.0000237866.70357.c6","volume":"8","author":"CM Eng","year":"2006","unstructured":"Eng CM, Germain DP, Banikazemi M, Warnock DG, Wanner C, Hopkin RJ, Bultas J, Lee P, Sims K, Brodie SE, Pastores GM, Strotmann JM, Wilcox WR: Fabry disease: guidelines for the evaluation and management of multi-organ system involvement. Genet Med. 2006, 8: 539-548. 10.1097\/01.gim.0000237866.70357.c6.","journal-title":"Genet Med"},{"key":"735_CR12","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1161\/CIRCULATIONAHA.109.849828","volume":"120","author":"CA Gange","year":"2009","unstructured":"Gange CA, Link MS, Maron MS: Utility of cardiovascular magnetic resonance in the diagnosis of Anderson-Fabry disease. Circulation. 2009, 120: e96-e97. 10.1161\/CIRCULATIONAHA.109.849828.","journal-title":"Circulation"},{"key":"735_CR13","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/clc.22088","volume":"36","author":"G Nucifora","year":"2013","unstructured":"Nucifora G, Miani D, Di Chiara A, Piccoli G, Artico J, Puppato M, Slavich G, De Biasio M, Gasparini D, Proclemer A: Infarct-like acute myocarditis: relation between electrocardiographic findings and myocardial damage as assessed by cardiac magnetic resonance imaging. Clin Cardiol. 2013, 36: 146-152. 10.1002\/clc.22088.","journal-title":"Clin Cardiol"},{"key":"735_CR14","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1161\/CIRCIMAGING.113.000482","volume":"6","author":"RB Thompson","year":"2013","unstructured":"Thompson RB, Chow K, Khan A, Chan A, Shanks M, Paterson I, Oudit GY: T1 mapping with cardiovascular MRI is highly sensitive for fabry disease independent of hypertrophy and sex. Circ Cardiovasc Imaging. 2013, 6: 637-645. 10.1161\/CIRCIMAGING.113.000482.","journal-title":"Circ Cardiovasc Imaging"},{"key":"735_CR15","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.jacc.2006.08.030","volume":"48","author":"PP Sengupta","year":"2006","unstructured":"Sengupta PP, Korinek J, Belohlavek M, Narula J, Vannan MA, Jahangir A, Khandheria BK: Left ventricular structure and function: basic science for cardiac imaging. J Am Coll Cardiol. 2006, 48: 1988-2001. 10.1016\/j.jacc.2006.08.030.","journal-title":"J Am Coll Cardiol"},{"key":"735_CR16","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1161\/CIRCULATIONAHA.108.794529","volume":"119","author":"F Weidemann","year":"2009","unstructured":"Weidemann F, Niemann M, Breunig F, Herrmann S, Beer M, St\u00f6rk S, Voelker W, Ertl G, Wanner C, Strotmann J: Long-term effects of enzyme replacement therapy on fabry cardiomyopathy: evidence for a better outcome with early treatment. Circulation. 2009, 119: 524-529. 10.1161\/CIRCULATIONAHA.108.794529.","journal-title":"Circulation"},{"key":"735_CR17","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.amjcard.2005.11.087","volume":"97","author":"M Beer","year":"2006","unstructured":"Beer M, Weidemann F, Breunig F, Knoll A, Koeppe S, Machann W, Hahn D, Wanner C, Strotmann J, Sandstede J: Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy. Am J Cardiol. 2006, 97: 1515-1518. 10.1016\/j.amjcard.2005.11.087.","journal-title":"Am J Cardiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-14-86.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2261-14-86\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-14-86","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-14-86.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T15:51:32Z","timestamp":1548172292000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/1471-2261-14-86"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,16]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["735"],"URL":"https:\/\/doi.org\/10.1186\/1471-2261-14-86","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,16]]},"assertion":[{"value":"19 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"86"}}